Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.91 USD | +5.66% | -8.23% | -32.98% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 181
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Device
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rebecca Kuhn
FOU | Founder | 64 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Cairn Seale
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-12-31 |
Martha Morrell
CTO | Chief Tech/Sci/R&D Officer | 66 | 97-11-18 |
Philip Taylor
IRC | Investor Relations Contact | - | - |
Stacey Ellul
LAW | General Counsel | - | 22-11-30 |
Irene Thomas
HRO | Human Resources Officer | 55 | 99-12-31 |
Dylan St. John
PRN | Corporate Officer/Principal | 46 | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Andrade
BRD | Director/Board Member | 52 | 21-10-31 |
Joseph Lacob
BRD | Director/Board Member | 68 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Uri Geiger
BRD | Director/Board Member | 56 | 23-01-04 |
Renee Ryan
BRD | Director/Board Member | 55 | 20-07-31 |
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rakhi Kumar
BRD | Director/Board Member | 44 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,768,128 | 23,068,317 ( 80.19 %) | 0 | 80.19 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.98% | 199M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- NPCE Stock
- Company NeuroPace, Inc.